Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Scientific (CORZZ) EBITDA (2021 - 2025)

Historic EBITDA for Core Scientific (CORZZ) over the last 5 years, with Q3 2025 value amounting to -$57.4 million.

  • Core Scientific's EBITDA fell 3931.68% to -$57.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$166.1 million, marking a year-over-year decrease of 77732.96%. This contributed to the annual value of -$19.2 million for FY2024, which is 31421.72% down from last year.
  • Core Scientific's EBITDA amounted to -$57.4 million in Q3 2025, which was down 3931.68% from -$26.3 million recorded in Q2 2025.
  • Over the past 5 years, Core Scientific's EBITDA peaked at $102.2 million during Q4 2021, and registered a low of -$1.0 billion during Q2 2022.
  • Its 5-year average for EBITDA is -$111.3 million, with a median of -$12.0 million in 2023.
  • Its EBITDA has fluctuated over the past 5 years, first crashed by 848992.47% in 2022, then skyrocketed by 62647.99% in 2024.
  • Over the past 5 years, Core Scientific's EBITDA (Quarter) stood at $102.2 million in 2021, then tumbled by 722.64% to -$636.1 million in 2022, then skyrocketed by 100.62% to $3.9 million in 2023, then plummeted by 1111.26% to -$39.8 million in 2024, then plummeted by 44.35% to -$57.4 million in 2025.
  • Its EBITDA was -$57.4 million in Q3 2025, compared to -$26.3 million in Q2 2025 and -$42.6 million in Q1 2025.